Drug Insights

Unlock the Power of Synapse: A Guide to Searching Minoxidil

18 February 2024
2 min read

Minoxidil, found in LONITEN Tablets manufactured by Pfizer, is a peripheral vasodilator that is commonly used to treat hypertension and alopecia. It works by relaxing blood vessels and increasing blood flow, which reduces blood pressure. As a potassium channel agonist and VGKCs modulator, minoxidil opens the potassium channels of smooth muscle cells in the blood vessels, allowing more potassium ions to flow out of the cells, resulting in relaxation of the vascular smooth muscle. In addition to treating hypertension, minoxidil is also used topically in solutions or foam formulations to promote hair growth and prevent further hair loss in individuals with androgenetic alopecia. Click on the image below to begin the exploration journey of Minoxidil through the Synapse database!

图形用户界面, 文本, 应用程序, 电子邮件

描述已自动生成

You can search for the latest pharmaceutical information such as drugs, targets, patents, transactions, clinical results, etc. through the Synapse database. Come and experience it!

图形用户界面, 文本, 应用程序, 聊天或短信

描述已自动生成

Promising Early Results from Johnson & Johnson's Phase 3 & 2 Trials for Generalized Myasthenia Gravis and Sjögren's Disease Treatments
Latest Hotspot
3 min read
Promising Early Results from Johnson & Johnson's Phase 3 & 2 Trials for Generalized Myasthenia Gravis and Sjögren's Disease Treatments
18 February 2024
Johnson & Johnson has announced encouraging initial findings from a critical Phase 3 trial with nipocalimab for treating generalized myasthenia gravis, as well as from a Phase 2 investigation in Sjögren's Disease.
Read →
Exploring DKN-01's R&D successes and its clinical results at the 2024 ASCO_GI
Exploring DKN-01's R&D successes and its clinical results at the 2024 ASCO_GI
18 February 2024
CRC, marked by Wnt pathway hyperactivation and DKK1 regulation, is effectively countered by DKN-01, an IgG4 antibody that neutralizes DKK1.
Read →
Technoderma's TDM-105795 Stage 2 Trial Shows Positive Hair Regrowth in Pattern Baldness
Latest Hotspot
3 min read
Technoderma's TDM-105795 Stage 2 Trial Shows Positive Hair Regrowth in Pattern Baldness
18 February 2024
The Stage 2 trial for Technoderma's drug, TDM-105795, reveals positive outcomes for hair regeneration in individuals with pattern baldness.
Read →
How to Effectively Search for Nitrofurantoin on Synapse
Drug Insights
2 min read
How to Effectively Search for Nitrofurantoin on Synapse
18 February 2024
Nitrofurantoin, an antibiotic medication approved in 1953 by Procter & Gamble, is used to treat uncomplicated lower urinary tract infections.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.